The presence of insulin-binding antibodies in the serums of insulin-treated subjects has been reported previously (1) . With I"ll-labeled insulin it has been shown that the antigen-antibody complexes do not precipitate, that the binding of insulin to antibody is a reversible process, and that, at constant antibody concentration, the ratio of bound insulin to free insulin is an inverse function of the concentration of insulin (1) .
In the present studies, experimental data on the reaction between insulin and insulin-binding antibody are tested against several theoretical models. The results are most compatible with a model composed of a univalent insulin reacting with two distinctly different orders of antibody sites. Data for equilibrium constants, forward and reverse velocity constants and various thermodynamic constants are presented in terms of the model chosen.
METHODS
Antiserums were obtained from insulin-treated diabetic and schizophrenic subjects generally at least 24 hours and frequently many weeks following the last injection of insulin and were stored frozen or at 40 C. for weeks or months prior to use.
Insulin-I131 was prepared from crystalline beef insulin' with specific activities of 10 to 100 mc. per mg. Methods employed in preparation and in protection of the insulin against extensive radiation damage have been described (2, 3) . However, because of the extremely high specific activities of the preparations and the trauma incident to the labeling procedure, storage and dilution, occasionally as much as 10 per cent of the insulin-I'3l was damaged by the time of use. Recent preparations, with which the bulk of the quantitative data has been obtained, have uniformly contained less than 5 per cent damaged components.
All dilutions were made in water or veronal buffer,2 0.1 ionic strength, pH 8.6 , to which was added 2 per cent ' We are indebted to Dr. 0. K. Behrens and Dr. C. W. Pettinga of the Eli Lilly laboratories for generous supplies of crystalline beef insulin. 2 No significant differences in binding were detected when duplicate specimens of the same antiserum were diluted in water and in veronal. serum albumin to minimize losses of insulin or antibody by adsorption on glassware.
Two types of experiments were performed. In one, henceforth termed "equilibrium state" studies, various relative concentrations of antiserum and insulin, including tracer quantities of insulin-I'3l, were incubated together at 370 C. The mixtures were allowed to come to equilibrium and were then analyzed for their content of free and bound insulin. No differences in the binding of insulin-I'3l and unlabeled crystalline insulin could be detected, i.e., at any particular insulin concentration the same degree of binding of insulin-I'3' was observed whether the insulin present was derived solely from the labeled insulin preparation or was primarily unlabeled insulin with only a tracer amount of insulin-I'3'. In the other type of experiment, frequently called "rate" studies but herein termed "transient state" studies, insulin and whole or diluted antiserum were each allowed to come to temperature equilibrium at 370 C. and then mixed together. The reaction mixtures were analyzed at intervals to determine the rate of formation of insulin-antibody complexes ("association"). The reverse reaction ("dissociation") was studied by adding high concentrations of nonradioactive insulin to the incubation mixtures; thus, insulin-I'31 dissociating from preformed insulin-antibody complexes was competitively inhibited from recombination with antibody.
The distribution of insulin-I'3l between free and bound fractions was determined by paper chromatographic methods which have been described previously (1) . In brief, these methods depend on the adsorption of free insulin to the paper at the site of application ("origin") while insulin bound to antibody migrates with the serum proteins. It has been noted previously (1) that during paper electrophoresis at 200 C., in runs lasting 18 to 24 hours, the paper may adsorb some of the insulin dissociating from preformed complexes during the run; this results in a "tailing" of insulin-I'3l along the path of migration of the complexes so that this procedure does not permit eminently satisfactory separation of the free and bound insulin present initially. However, movement of serum proteins away from the origin, sufficient for resolution of free and bound insulin, can be effected within 20 to 30 minutes by hydrodynamic flow chromatography combined with electrophoresis (1) . Since the rates of both forward and reverse reactions are markedly decreased by lowering the temperature, all chromatographic runs were performed in a cold room at 40 C. Under these conditions uncomplexed insulin becomes bound to the paper in a fraction of a minute and generally neither the forward nor the reverse reaction occurs to any significant extent after the mixtures are 1996 QUANTITATIVE ASPECTS OF INSULIN-ANTIBODY REACTION applied to the paper strips. 3 In order to maintain reproducible conditions during chromatography of samples at different serum dilutions, 50 ,ul. of undiluted control plasma was added to all diluted samples at the time of chromatography.
Another method also was used to determine the rates of dissociation of preformed complexes. After incubation of antiserum and insulin-I'3l, the mixture was added to a source of active "insulinase" (concentrated rat liver homogenate) which is capable of destroying 60 per cent of trace amounts of unbound insulin-I13' in the first minute but does not act on bound insulin (4) . The rate of destruction of the insulin-I'3l is therefore limited by the rate of dissociation of the complex. The rate of insulin-I'3l degradation was evaluated by analysis of aliquots of the mixtures for trichloracetic acid precipitable and nonprecipitable radioactivity (4) .
The ability of serum to degrade insulin-I'3l on prolonged incubation at 370 C. has been observed (1) . Although many serums are relatively free of such action, some serums are quite troublesome and have to be discarded. Aging and products of hemolysis appear to correlate with the presence of insulin-degrading factors. Whether hemoglobin itself is responsible is not known but since sulfhydryl-containing substances such as H2S, cysteine and thioglycollate produce similar changes, it appears possible that reduced glutathione, or -SH groups of blood proteins are responsible for the changes observed in the insulin-I'31.
These alterations are characterized by the appearance of I'l3l-labeled fractions which bind quite firmly to all serum proteins although mainly to a2-globulin (1) ; deiodination per se is minimal. Damaged fractions produced during the course of preparation of insulin-I'3l also bind rather indiscriminately to all serum proteins (1) (2) (3) . Correction for the nonspecific binding of I'31-labeled fractions has been made in each experiment by simultaneously running control non-immune plasma samples for evaluation of the 3 When antibody concentration is extremely high as in undiluted serums from insulin-resistant subjects, the forward reaction may continue to a significant extent until the plasma proteins have migrated away from the origin, which may take several minutes. In such cases antibody may actually elute a fraction of the insulin previously adsorbed to the paper. For these reasons and also to slow down the rate of the forward reaction to measurable levels, serums of high antibody titer were always diluted appreciably for transient state studies. Although, after prolonged chromatography, slight elution of insulin, adsorbed to paper by the solvent, can be detected as a broadening of the peak at the origin, the absence of any significant elution under the conditions employed here has been demonstrated in experiments with undiluted control plasma and undamaged insulin-I'3' preparations. In these cases there is no detectable radioactivity migrating away from the peak at the origin. The absence of any significant loss of bound insulin-II3' from the complexes by dissociation and adsorption to paper during chromatographic development has also been established by the observation that over 99 per cent of trace insulin-I'3l migrates with the serum proteins in serums with high antibody titers. damaged moiety in the preparation employed and by electrophoretic analysis for evaluation of "incubation damage." In most experiments these corrections amounted' to about 5 per cent of the undamaged insulin-I'3l. Where damage was significantly in excess of 10 per cent, results are not reported.
Analysis. Since the antigen-antibody complexes under consideration are soluble,4 direct determination either of the amount of antibody present or of the relative molecular proportions of insulin and antibody in the complexes formed has not been possible. It is necessary, therefore, to consider a number of possible models and to exclude those which are clearly inconsistent with the experimental data. The analysis presented below is employed for this purpose as well as for evaluation of the kinetic data.
The assumption that the law of mass action is applicable to the reactions between antigen and antibody forms the basis of all theoretical considerations which follow. 
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The characteristics of "dissociation" curves will allow for identification of AgAb and AgAb2 with the slowly and rapidly dissociating complexes. If AgAb dissociates less rapidly than AgAb2 (i.e., k', > k'), the slope of the dis- Figure 7 .
sociation curve will become steeper with time (or, if the rates differ greatly, say by a factor of 10 or more, the curve will appear to approximate a single exponential component). Only if the converse is true (i.e., k' > k',) can the initial segment of the dissociation curve have the sharpest slope.'0 Unlike the case of univalent insulin reacting with two orders of antibody sites, the relative amounts of "univalent" and "divalent" complexes are not obtained simply from the extrapolation of the final component to zero time since the amounts in a and b at any time, t, following inhibition of recombination are described by the following equations: 
F a straight line might have appeared to provide a satisfactory fit, which suggests that the linearrelationship in Figure 4 was probably more apparent than real.
In some cases, the experimental data could be fitted almost equally well by assuming either a univalent insulin reacting with two different orders of antibody combining-sites or a divalent insulin reacting with a single order of antibody combining-sites ( Figure 5 ). These were cases in which the slope of B vs. B was not particularly steep for low values of B. For cases in which a steep slope in the region of low B was observed (e.g., D. C. and Pr., Figure 6 ) no fit was possible for the case of a divalent insulin and a single order of combining-sites even if Kc was assumed to be very much greater than K;11 however, a 11 This does not, of course, exclude the cases of divalent or multivalent insulin reacting with two or more orders of antibody combining-sites. Figure 7 .
Transient state experiments
In all cases studied there appeared to be two grossly different rates at which insulin at tracer concentrations became bound to antibody (Figure 8) ; i.e., on analysis, the approach to the equilibrium value took the form of the sum of two exponential components. Similarly, the formed antigen-antibody complexes were heterogeneous in that two rates of dissociation were observed (Figures 9a and b) . The more rapid of these rates ranged from about 3 (Table I) . In one serum, the rates of dissociation were studied both with liver insulinase and by paper chromatography; the values for each of the two rates were in reasonable agreement by the two methods (Figures 9a and b) .
In Table I ) the observed rate of complex formation was significantly greater than the calculated rate. It could not be determined whether these discrepancies were attributable to experimental errors or to defects in the theoretical models.
At equilibrium, in experiments with tracer concentrations of insulin-I'1l, frequently half or more than half of the bound insulin was in the slowly B dissociating complex even when p was as low as 0.65. However, after short periods of incubation, most of the complex was generally in the rapidly dissociable form, the ratio of slowly to rapidly dissociating components increasing with time of incubation ( Figure 10 ). Transient state studies on the serum of J. Ha. were analyzed according to the models of univalent insulin reacting with two orders of antibody sites (Equations 32 through 34, Figure 10 ) and of divalent insulin reacting with a single order of antibody sites (Equations 38 through 40; curve analysis not shown). The reaction rates of the two complexes calculated from F vs. t for both models were quite similar'2 (Table II) (Figure 11 , Table III ). In all cases the initial segments of "dissociation" curves showed the sharpest slopes as in (Figure 12 ). The initial slopes of the dissociation curves were always steeper than the final slopes, which in itself would require, in the case of divalency of insulin, that k', be less than k'.
As expected, the ratio between slowly and rapidly dissociating components is lower at load insulin concentration than at tracer insulin concentration ( Figure 12 ). This was to be expected with either of the postulated models.
DISCUSSION
The antigen-antibody system under study here is unusual in several respects. Nonprecipitability of the complexes was observed previously in antiserum obtained from nonresistant subjects (1) and had been attributed either to the extremely low concentrations of complexes or, alternatively, to the possibility that the insulin- 1) On dilution of antiserum, the ratio B/F at tracer insulin concentrations falls linearly with the reciprocal of the dilution factor. If insulin were multivalent, B/F should be a function of some power of the dilution factor.
2) The ratio between rapidly and slowly dissociating complexes formed at trace insulin concentrations is not affected by four-to tenfold dilution of antibody concentration in individual antiserums. It has been pointed out that if "multivalent complexes" existed, they should be more prevalent at higher than at lower antibody concentrations and that the more dilute antiserum should contain a smaller proportion of slowly dissociating complexes. Furthermore, antiserum of very low antibody concentration should be virtually free of slowly dissociating complexes if insulin is multivalent. These requirements are incompatible with the experimental observations.
For reasons given below, the possibility of an insulin valency greater than two may be excluded almost with certainty. If, therefore, consideration is restricted to the possibility of divalency as opposed to univalency, the following points argue against divalency.
3) In all antiserums, the two single order rate constants of dissociation (for release of insulin) differ by a factor of 50 to 100. As emphasized above, were the rapidly and slowly dissociating complexes to be correlated with "univalent complexes" and "divalent complexes," the latter would have to be identified with the slowly dissociating complexes. It then becomes difficult to explain why the rate of release of insulin from "divalent complexes" should be so much slower than from "univalent complexes" without postulating that the presence of a second antibody molecule increases, many fold, the strength of binding of insulin in the complex (i.e., k't << k'). Although such a possibility is not out of the question, especially in view of the suggestion of Talmage (7) that inter-antibody linkages may be formed, it appears unlikely to us in the present instance.
4) The observation that most of the bound insulin may be in the slowly dissociating component even when as little as 40 per cent of trace concentrations of insulin is bound to antibody is incompatible with the slowly dissociating component being "divalent complex" unless K, is significantly greater than K.
5) The experimental curves for B/F vs. B in the equilibrium studies could frequently not be fitted to theoretical curves derived from the model for a divalent insulin and a single order of antibody combining-sites. In these cases, the experimental curves were actually of a form completely incompatible with such a model but were compatible with, and could be fitted closely by, a theoretical curve derived from the model of a univalent insulin reacting with two different antibody sites.
6) Finally, independent evidence that insulin is not multivalent is available from studies on the sedimentation velocities of I'3l-insulin-antibody complexes formed in undiluted serums of high titer in the region of marked antibody excess. These sedimentation velocities were found to be only 5 to 6 per cent greater than the sedimentation velocity of I'll-labeled y-globulin (8) . If the insulin-binding antibody does not differ significantly in size and shape from yglobulin, these findings are inconsistent with the presence of complexes that contain more than a single antibody molecule regardless of the geometrical configuration of the complex, and are certainly incompatible with complexes containing more than two antibody molecules.
Thus, heterogeneity of antibody combiningsites rather than multivalency of insulin is favored as an explanation for the heterogeneity of insulinantibody complexes. The studies of Karush (9) have revealed that antibodies produced against haptenic dye groups react with the haptens in a manner consistent with the conclusion of Pauling, Pressman and Grossberg (10) that the distribution of free energy of binding can be described by a Gaussian error function. Therefore, even a single "order" of antibody combining-sites may be expected to react heterogeneously to some degree. However, the two widely different rates of dissociation of complexes in the insulin-antibody system cannot readily be interpreted simply in terms of a normal distribution of binding energies, but must be ascribed to groups.of distinctly different antibodies. That a distribution of energies within each group may exist can hardly be denied. The K values being measured simply represent average values within each group.
The evidence cited for the presence of two orders (at least) of antibody combining-sites has been indirect, derived essentially from exclusion of alternative models and from consistency of the experimental data with a theoretical model. However, in studies reported elsewhere (11) it has been shown that crystalline insulins obtained 2011 from different mammalian species show marked differences in direct reaction and in competitive cross-reactions with individual antiserums. Thus, beef and sheep insulins usually bind much more strongly than does pork or horse insulin and at certain concentrations the presence of beef insulin or sheep insulin produces, by competitive inhibition, a lower B/F ratio for pork insulin-I'3l and horse insulin-I'3l than do pork insulin and horse insulin themselves at the same concentrations. When pork or horse insulin is added in concentrations sufficient to result in a very low B/F ratio for these insulins, beef insulinI13l may still be bound at a relatively high ratio. (14) . The sequence in these positions in beef insulin is ala, ser, val; in sheep insulin ala, gly, val; in pork insulin thr, ser, ileu and in horse insulin thr, gly, ileu.
The differences in reaction with all these insulins which are identical except at the site under discussion, at least so far as amino acid sequence is concerned, suggest strongly that this site is an antigenic site. But antigenic determinacy could reside in several groups in this site and antibody molecules directed to several of these groups could differ strikingly in their affinity for insulin. It is therefore not possible to assign the different antibody combining-sites to beef insulin antibody and to pork insulin antibody specifically. Studies with serums from persons immunized with a single species insulin are obviously indicated. How~rever, it is of some interest that rabbit anti-beef insulin serum'3 forms heterogeneous complexes with beef insulin.
It should be emphasized here that evidence favoring univalency of insulin in its reaction with antibody does not necessarily imply that there is but a single antigenic site. The presence of two or more antigenic sites in insulin is quite compatible with univalency of insulin inasmuch as steric restrictions might well account for the inability of a single relatively small insulin molecule to bind antibody at more than a single antigenic site even if multiple sites are present.
It has been noted that the K's were generally lower in serums with higher antibody concentrations. Although there are definite exceptions, the general tendency would suggest that in this system, at least, a marked increase in antibody synthesis is associated with the production of antibody of lower affinity for the antigen.
Several other matters remain for critical comment. It has already been observed that if the antibody molecules are assumed to be divalent, the possibility cannot be excluded that the equilibrium constant for each site might be altered by the presence of an insulin molecule at the other site. It has not been feasible to evaluate this possibility, which is of importance only toward the side of antigen excess, nor are we aware of any relevant studies in any other immunologic system. It is clear that this complication may be ignored in the region of marked antibody excess and can in no way be considered responsible for the heterogeneity of complexes at trace insulin concentrations.
Another possible complication resides in the characteristic tendency of insulin to polymerize at high concentrations. In this work insulin has been assumed to be homogeneous and calcula- 13 We are indebted to Drs. E. Arquilla and A. Stavitsky for this antiserum.
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tions have been based on a molecular weight of 6,000. Whether the individual insulin molecule weighs 6,000, 12,000 or 24,000 is of little importance in the results since a constant factor of 1, one-half or one-fourth need only be applied to the calculated molar concentrations. However, should monomers, dimers, trimers, and so forth coexist in the mixtures being studied, analysis of the kinetics of reaction with antibody would become extremely complicated, for not only might a single antibody combining-site be complexed with one, two, three or more insulin monomer units but also, in the process of formation of dimers, trimers, and so forth, the antigenic sites might be masked or shielded in such a way as to inhibit or prevent reaction with the antibody. Conversely, if insulin polymerized into such a form as to leave the antigenic sites of several of the monomers exposed, it might be possible to form large antigen-antibody aggregates despite univalency of the insulin monomer. It has already been noted that ultracentrifugal sedimentation studies exclude the last possibility.
Moreover, it appears unlikely that significant amounts of insulin polymers were ever present under the conditions of the experiments reported here. The studies of Fredericq (15) have provided evidence that, in concentrations < 0.1 per cent, the 6,000 molecular weight monomer predominates above pH 9 with preparations dialyzed free of zinc.'4 In the present study the solutions employed never exceeded 0.001 per cent and usually were in the range 0.000001 to 0.00005 per cent. It seems highly improbable that the percentage of dimers in these solutions could ever have been significant.
Finally, a word may be said about the thermodynamics of the reaction of insulin with insulinbinding antibody. The standard free energy change (AFO), calculated from the equilibrium data according to the reaction isotherm, AFo = -RT lnK amounts to about minus 10 to 11 Kcal. per Mole and minus 11 to 14 Kcal. per Mole for reaction 14 In the present studies duplicate runs in the usual veronal buffer, pH 8.6, and in glycine buffer, pH 10, have yielded identical results for binding of insulin to antibody. All insulin-I'3l solutions were thoroughly dialyzed and it has already been noted that insulin-I131 showed no differences from unlabeled insulin with respect to binding by antibody. It is therefore evident that many factors other than antibody concentration per se will enter into determining the effect of antibodies on insulin requirements in individual cases. Among these may be listed: a) the rate at which insulin-antibody complexes are removed from the circulation which together with the rate of turnover of uncomplexed antibody will equal the rate of antibody synthesis in the steady state; b) the ratio of bound to free insulin at the free insulin concentration necessary for control of diabetes; c) the extent of saturation of the antibody at this ratio; and d) the rate at which complexes form and dissociate (which will determine how much of a given insulin dose will escape to the tissues before being bound or rebound to antibody). There may still remain many other factors not yet considered, but it is hoped that future study will aid in their elucidation.
SUMMARY AND CONCLUSIONS 1. Kinetic aspects of the reaction between insulin and insulin-binding antibody were studied with antiserums from insulin-resistant and nonresistant human subjects.
2. Insulin-antibody complexes are soluble throughout the range of marked antibody excess to marked antigen excess. 3. In antiserums from nonresistant subjects, insulin-binding capacities generally did not exceed about 10 units insulin per L. serum, whereas insulin-binding capacities ranged from 50 units per L. to over 500 units per L. in antiserums from insulin-resistant patients. 4 . The methods employed permit detection of less than 1 m,ug. insulin-binding antibody, assuming the molecular weight of insulin to be 6,000. 
